In brief
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g210 (Published 14 January 2014) Cite this as: BMJ 2014;348:g210
This article has a correction. Please see:
Osteoporosis drug is suspended in Europe: The European Medicines Agency has recommended that strontium ranelate (marketed by Servier as Protelos) no longer be used to treat osteoporosis, after an in-depth review. The review found that for every 1000 patient years there were four more cases of serious heart problems and four more cases of blood clots or blockages of blood vessels among patients taking the drug than among patients taking placebo. In April 2013 the agency recommended restricting the use of the drug to reduce the risk of heart problems.
Slough hospital is warned on safety and bullying: England’s health and social care regulator has issued six warning notices to Heatherwood and Wexham Park Hospitals NHS Foundation Trust …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.